Dongyoung Park is a Senior Scientist in the CDO Upstream Development group at Samsung Biologics. Over his seven years with the company, he has driven multiple platform development and enhancement initiatives, establishing strong technical leadership in bioprocess optimization and bioreactor scale-up.
